41 unchanged sentences
Wolfgang Renz (incorporated by reference to our Current Report on Form 8-K filed on March 26, 2015)
+Added: Director Services Agreement dated February 26, 2015 with Dr.
+Added: Wolfgang Renz (incorporated by reference to our Current Report on Form 8-K filed on March 26, 2015)
Consulting Services Agreement dated February 25, 2015 with Dr.
Giora Davidai (incorporated by reference to our Current Report on Form 8-K filed on March 26, 2015)
+Added: Consulting Services Agreement dated February 25, 2015 with Dr.
+Added: Giora Davidai (incorporated by reference to our Current Report on Form 8-K filed on March 26, 2015)
Director Services Agreement dated November 19, 2015 with Dr.
1 unchanged sentence
Director Services Agreement dated November 19, 2015 with Dr.
+Added: Patrick Frankham (incorporated by reference to our Quarterly Report on Form 10 Q filed on December 15, 2015)
+Added: Director Services Agreement dated November 19, 2015 with Dr.
Wolfgang Renz (incorporated by reference to our Quarterly Report on Form 10 Q filed on December 15, 2015)
+Added: Director Services Agreement dated November 19, 2015 with Dr.
+Added: Wolfgang Renz (incorporated by reference to our Quarterly Report on Form 10 Q filed on December 15, 2015)
Consulting Services Agreement dated November 19, 2015 with Dr.
+Added: Giora Davidai (incorporated by reference to our Quarterly Report on Form 10‑Q filed on December 15, 2015)
+Added: Consulting Services Agreement dated November 19, 2015 with Dr.
Giora Davidai (incorporated by reference to our Quarterly Report on Form 10-Q filed on December 15, 2015)
+Added: Plan of Merger and Acquisition Agreement between our company and IndUS Pharmaceuticals, Inc., dated November 4, 2015 (incorporated by reference to our Current Report on Form 8‑K filed on November 23, 2015 and our Current Report on Form 8‑K/A filed on February 3, 2016)
Plan of Merger and Acquisition Agreement between our company and IndUS Pharmaceuticals, Inc., dated November 4, 2015 (incorporated by reference to our Current Report on Form 8-K filed on November 23, 2015 and our Current Report on Form 8-K/A filed on February 3, 2016)
Employment Agreement dated November 20, 2015 with Dr.
+Added: Pravin Chaturvedi (incorporated by reference to our Quarterly Report on Form 10‑Q filed on December 15, 2015)
+Added: Employment Agreement dated November 20, 2015 with Dr.
Pravin Chaturvedi (incorporated by reference to our Quarterly Report on Form 10-Q filed on December 15, 2015)
1 unchanged sentence
Ahmad Doroudian (filed on April 29, 2016 with our Annual Report on Form 10-K)
+Added: Employment Agreement dated February 1, 2016 with Dr.
+Added: Ahmad Doroudian (filed on April 29, 2016 with our Annual Report on Form 10-K)
Employment Agreement dated February 1, 2016 with Moira Ong (filed on April 29, 2016 with our Annual Report on Form 10-K)
−Removed: Consulting Services Agreement dated February 1, 2016 with Soho Capital Inc.(filed on April 29, 2016 with our Annual Report on Form 10-K)
+Added: Employment Agreement dated February 1, 2016 with Moira Ong (filed on April 29, 2016 with our Annual Report on Form 10-K)
+Added: Consulting Services Agreement dated February 1, 2016 with Soho Capital Inc.
+Added: (filed on April 29, 2016 with our Annual Report on Form 10-K)
+Added: Consulting Services Agreement dated February 1, 2016 with Soho Capital Inc.
+Added: (filed on April 29, 2016 with our Annual Report on Form 10-K)
+Added: Convertible debenture agreement dated September 29, 2016 with Avro Capital Partners Inc.
+Added: Convertible debenture agreement dated September 29, 2016 with Avro Capital Partners Inc.
+Added: Exchange Agreement between our company, IndUS Pharmaceuticals, Inc.
+Added: and Pravin Chaturvedi, dated September 11, 2017 (incorporated by reference to our Current Report on Form 8-K filed on September 12, 2017)
+Added: Exchange Agreement between our company, IndUS Pharmaceuticals, Inc.
+Added: and Pravin Chaturvedi, dated September 11, 2017 (incorporated by reference to our Current Report on Form 8-K filed on September 12, 2017)
+Added: Licensing Agreement between our company and Altum Pharmaceuticals Inc.
+Added: dated September 12, 2017 (incorporated by reference to our Current Report on Form 8-K filed on September 12, 2017)
+Added: Licensing Agreement between our company and Altum Pharmaceuticals Inc.
+Added: dated September 12, 2017 (incorporated by reference to our Current Report on Form 8-K filed on September 12, 2017)
+Added: Debt Forgiveness Agreement dated July 31, 2017 between our company and Dr.
+Added: Ahmad Doroudian
+Added: Debt Forgiveness Agreement dated July 31, 2017 between our company and Dr.
+Added: Ahmad Doroudian
+Added: Debt Forgiveness Agreement dated July 31, 2017 between our company and Moira Ong
+Added: Debt Forgiveness Agreement dated July 31, 2017 between our company and Moira Ong
+Added: Debt Forgiveness Agreement dated July 31, 2017 between our company and Soho Capital Inc.
+Added: Debt Forgiveness Agreement dated July 31, 2017 between our company and Soho Capital Inc.
Rule 13a-14(d)/15d-14(d) Certifications
+Added: Rule 13a-14(d)/15d-14(d) Certifications
Section 302 Certification under the Sarbanes-Oxley Act of 2002 of Principal Executive Officer
+Added: Section 302 Certification under the Sarbanes-Oxley Act of 2002 of Principal Executive Officer
Section 302 Certification under the Sarbanes-Oxley Act of 2002 of Principal Financial Officer
+Added: Section 302 Certification under the Sarbanes-Oxley Act of 2002 of Principal Financial Officer
Section 1350 Certifications
+Added: Section 1350 Certifications
Section 906 Certification under the Sarbanes-Oxley Act of 2002 of Principal Executive Officer
+Added: Section 906 Certification under the Sarbanes-Oxley Act of 2002 of Principal Executive Officer
Section 906 Certification under the Sarbanes-Oxley Act of 2002 of Principal Financial Officer
+Added: Section 906 Certification under the Sarbanes-Oxley Act of 2002 of Principal Financial Officer
Additional Exhibits
+Added: Additional Exhibits
Audit Committee Charter (filed on June 17, 2015 with our Annual Report on Form 10K/A)
+Added: Audit Committee Charter (filed on June 17, 2015 with our Annual Report on Form 10K/A)
Stock Option Plan (filed on November 25, 2015 with our Definitive Proxy Statement on Schedule 14A)
+Added: Stock Option Plan (filed on November 25, 2015 with our Definitive Proxy Statement on Schedule 14A)
Interactive Data Files
+Added: Interactive Data Files
XBRL Instance Document
+Added: XBRL Instance Document
XBRL Taxonomy Extension Schema Document
+Added: XBRL Taxonomy Extension Schema Document
XBRL Taxonomy Extension Calculation Linkbase Document
+Added: XBRL Taxonomy Extension Calculation Linkbase Document
XBRL Taxonomy Extension Definition Linkbase Document
+Added: XBRL Taxonomy Extension Definition Linkbase Document
XBRL Taxonomy Extension Label Linkbase Document
+Added: XBRL Taxonomy Extension Label Linkbase Document
XBRL Taxonomy Extension Presentation Linkbase Document
+Added: XBRL Taxonomy Extension Presentation Linkbase Document
__________ * Filed herewith
1 unchanged sentence
PIVOT PHARMACEUTICALS INC.
−Removed: June 13, 2017
−Removed: /s/ Pravin Chaturvedi
−Removed: Pravin Chaturvedi
+Added: September 15, 2017
+Added: /s/ Patrick Frankham
+Added: Patrick Frankham
Chief Executive Officer and Director
(Principal Executive Officer)
−Removed: June 13, 2017
+Added: September 15, 2017
/s/ Moira Ong
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.